In The News
Respect@Work reforms will increase litigation but could benefit employers
Insurers on hook for Opal Tower class action costs after failed appeal
Justin Hemmes’ Establishment wins trade mark spat with Brisbane restaurant
No ‘bottomless pit’: Class action administrator put on notice about costs
Lundbeck wins appeal in decade-long IP battle with Sandoz over Lexapro
Seven faces Fair Work suit by former Spotlight journalist
Medtronic penalised $22M over sale of bone graft kits without regulatory OK
Harvey Norman hit with second class action over ‘junk’ warranties
CIMIC loses appeal against insurers over coverage for Iraq bribery cases
Super Retail appeal to have ‘significant impact’ on settlements, court told
Please login to bookmarkClose

Pharmaceuticals giant Lundbeck has succeeded in overturning IP Australia’s decision granting Novartis unit Sandoz a licence to sell a generic version of top-selling antidepressant Lexapro.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?
Lost your password?

Contact us to enquire about group subscriptions.
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au